Therapy News and Research

RSS

The impact of COVID-19 on dialysis patients

In this interview, News-Medical speaks to Professor Simon Davies and Dr. Raymond Vanholder about the impact of COVID-19 on kidney dialysis patients.

1 Jul 2021

COVID-19 vaccines are effective in 94% of cancer patients, shows study

In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients exhibited no response raised questions about how their protection against the virus will be addressed moving forward.

1 Jul 2021

Reactive oxygen species are important components in cancer treatments

Reactive oxygen species (ROS) are highly reactive chemicals which contain oxygen radicals. Hypochlorous acid, peroxides, superoxide, singlet oxygen, alpha-oxygen and hydroxyl radicals are the major examples of ROS, which are familiar to persons from many walks of life as they are used in many domestic and industrial processes.

1 Jul 2021

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors

Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects.

30 Jun 2021

Researchers turn to machine learning to predict when immunotherapy will be effective

When it comes to defense, the body relies on attack thanks to the lymphatic and immune systems. The immune system is like the body's own personal police force as it hunts down and eliminates pathogenic villains.

30 Jun 2021

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

Today, the U.S. Food and Drug Administration approved Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) as a component of a chemotherapy regimen to treat acute lymphoblastic leukemia and lymphoblastic lymphoma in adult and pediatric patients who are allergic to the E. coli-derived asparaginase products used most commonly for treatment.

30 Jun 2021

Ohio professor receives NIH grant to study age-related changes in motor neuron excitability

Brian Clark, Ph.D., professor of physiology and neuroscience in Ohio University Heritage College of Osteopathic Medicine's Department of Biomedical Sciences, received a five-year, nearly $3 million National Institutes of Health grant to conduct a series of animal and human studies to better understand the mechanisms and clinical relevance of age-related changes in motor neuron excitability.

30 Jun 2021

Study finds higher risk of pre-eclampsia, hypertension in pregnancies derived from frozen embryos

A large cohort study drawn from the national IVF registry of France, which included almost 70,000 pregnancies delivered after 22 weeks gestation between 2013 and 2018, has found a higher risk of pre-eclampsia and hypertension in pregnancies derived from frozen-thawed embryos.

30 Jun 2021

Strength training for breathing muscles lowers blood pressure, improves vascular health

Working out just five minutes daily via a practice described as "strength training for your breathing muscles" lowers blood pressure and improves some measures of vascular health as well as, or even more than, aerobic exercise or medication, new CU Boulder research shows.

30 Jun 2021

Is mild COVID-19 in children due to stronger antiviral innate immunity in the upper airway?

A new preprint on the medRxiv* server adds fuel to this train of thought, showing that the required cell program is already active in children – namely, a higher expression of specific pattern recognition receptors (PRRs), which mediate an interferon (IFN) response.

30 Jun 2021

Higher risk of preeclampsia and pregnancy-induced hypertension as a result of embryo freezing for IVF

Researchers have established a strong association between the risk of developing hypertension and the artificial cycle for frozen-thawed embryo transfer.

30 Jun 2021

Researchers identify key protein that allows cancer-destroying viruses to enter tumor cells

Researchers from the Laboratory of Oncolytic-Virus-Immuno-Therapeutics (LOVIT) at the LIH Department of Oncology (DONC) are working on the development of novel anticancer strategies based on oncolytic viruses, "good" viruses that can specifically infect, replicate in and kill cancer cells.

30 Jun 2021

New biomarkers can predict HIV remission after antiretroviral therapy interruption

New biomarkers that predict HIV remission after antiretroviral therapy (ART) interruption are critical for the development of new therapeutic strategies that can achieve infection control without ART, a condition defined as functional cure.

29 Jun 2021

LSL60101 compound improves cognitive deficit in murine models with Alzheimer’s

The LSL60101 compound, a specific ligand of the I2-IR receptors in the brain, could shed light on the development of future strategies against Alzheimer's disease.

29 Jun 2021

UTA chemist develops cancer medication that uses light to destroy tumor cells

A chemist at The University of Texas at Arlington is developing a cancer medication that uses light to target and destroy tumor cells in a process known as photodynamic therapy (PDT).

29 Jun 2021

New study investigates alternative ways to prevent, treat kidney infections

Ten IU School of Medicine researchers out of a team of 11 scientists, are responsible for the findings of a new study they conducted to investigate alternative ways to treat kidney infections.

29 Jun 2021

Study investigates the link between skeletal muscle proteome and type 2 diabetes

Globally, more than 400 million people have diabetes, most of them suffering from type 2 diabetes.

29 Jun 2021

How does dexamethasone therapy work in severe COVID-19?

The possible mechanisms that result in dexamethasone being an effective drug against severe SARS-CoV-2 infection are investigated in a new study. The paper’s authors advance the hypothesis that SARS-CoV-2 infection induces cell-specific insensitivity to glucocorticoids, possibly as an unintentional result of the viral replication cycle.

29 Jun 2021

Nanotechnology and the fight against COVID-19

In a review paper published in the open-access MDPI journal Viruses, a team of researchers explored the potential of nanotechnology to alleviate the current and future coronavirus burden. The team focused on its potential role in the detection, diagnosis, protection, and treatment of SARS-CoV-2 infection.

29 Jun 2021

Black male veterans more likely to receive radiation or surgery for prostate cancer than non-Black men

Black men most likely to benefit from advanced prostate cancer therapies are 11 percent less likely to get them than non-Black men. This happens despite apparent equal opportunities in obtaining health care services, a new study in American veterans shows

29 Jun 2021

Therapy News and Research

The impact of COVID-19 on dialysis patients

COVID-19 vaccines are effective in 94% of cancer patients, shows study

Reactive oxygen species are important components in cancer treatments

RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors

Researchers turn to machine learning to predict when immunotherapy will be effective

FDA approves alternative component of chemotherapy regimen to treat acute lymphoblastic leukemia

Ohio professor receives NIH grant to study age-related changes in motor neuron excitability

Study finds higher risk of pre-eclampsia, hypertension in pregnancies derived from frozen embryos

Strength training for breathing muscles lowers blood pressure, improves vascular health

Is mild COVID-19 in children due to stronger antiviral innate immunity in the upper airway?

Higher risk of preeclampsia and pregnancy-induced hypertension as a result of embryo freezing for IVF

Researchers identify key protein that allows cancer-destroying viruses to enter tumor cells

New biomarkers can predict HIV remission after antiretroviral therapy interruption

LSL60101 compound improves cognitive deficit in murine models with Alzheimer’s

UTA chemist develops cancer medication that uses light to destroy tumor cells

New study investigates alternative ways to prevent, treat kidney infections

Study investigates the link between skeletal muscle proteome and type 2 diabetes

How does dexamethasone therapy work in severe COVID-19?

Nanotechnology and the fight against COVID-19

Black male veterans more likely to receive radiation or surgery for prostate cancer than non-Black men

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News